CORONA
CORONA Remedies LimitedNSEMarket Closed · NSE · INR
Open
₹2,075
High
₹2,095
Low
₹2,018.9
Prev Close
₹2,064.9
Market Cap
₹12.61 K Cr
Mid Cap
P/E (TTM)
68.1
EPS
₹30.28
Div Yield
0.48%
P/B Ratio
16.89
ROE
24.8%
Key Metrics
Analyst Ratings(3 analysts)
Target Price
₹1,929
-6.5% upside
Current price: ₹2,062
Upcoming Events
What If I Had Invested?
Chart data not available for this range
AI Analysis
Get AI-powered sentiment analysis, strengths, risks, and outlook for this stock.
AI Technical Analysis
Buy/sell zones with live web research
Get AI-generated buy zones, sell targets, stop-loss levels and a technical narrative — powered by AI with live web search for the latest news and analyst moves.
Patterns are measured on real price data, then AI-validated. Pattern detection is free when nothing clean is found.
About
CORONA Remedies Limited, a pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products. It provides products in women's healthcare, cardio-diabeto, pain management, urology, thyroid management, respiratory, nutraceuticals, gastroenterology, and other therapeutic a...
Technical Indicators
Quality scores
Valuation bands
Intrinsic value calculators
Peer Comparison
Dividend History
Recent: ₹10.00/shareRecent Filings (NSE)
Raw NSE filings — full text + attachments. Tap any row for an AI summary that explains what it means for the stock.
Institutional Deals(NSE)
Source: NSE India. Block deals ≥5L shares or ≥₹10Cr. Bulk deals ≥0.5% of shares.
Governance Scorecard
AlphaView compositeFund Actions
News
News sourced from RSS feeds. Headlines link to original articles.
Disclaimer: This is AI-generated educational information, not investment advice. Stock data is delayed by up to 15 minutes. Past performance does not guarantee future results. Please consult a SEBI-registered investment advisor before making investment decisions.